Koshkin, Vadim S.
Grivas, Petros
Article History
First Online: 11 April 2018
Compliance with Ethical Standards
:
: Vadim S. Koshkin declares that he has no conflict of interest.Petros Grivas has received compensation from Genentech, Dendreon, Bayer, Merck, Bristol-Myers Squibb, Exelixis, AstraZeneca, Biocept, Clovis Oncology, and EMD Serono for service as a consultant; participated in educational, unbranded,notproduct-related speaker’s program (after providing direct input for slides content) for Genentech and Bristol-Myers Squibb; and received support for conduction of clinical trials (to Cleveland Clinic Foundation) from Genentech, Bayer, Merck, Mirati, Oncogenex, Pfizer, Bristol-Myers Squibb, and AstraZeneca.
: This article does not contain any studies with human or animal subjects performed by any of the authors.